Clin2
NCT05651347Possibly a fitRecruiting

Melatonin in pregnancy to protect babies with slow growth

Fetal Growth RetardationStillbirth and Fetal DeathPregnancy Preterm

Treatments studied

Part of Genetic & congenital, Women’s health & pregnancy clinical trials.

This trial studies whether taking melatonin during pregnancy can help protect the baby’s brain and organs in cases of poor fetal growth. It focuses on pregnancies at a specific gestational age with signs that the placenta may not be working well.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
336 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are pregnant with one baby (not twins or more).
  • Your baby has severe slow growth based on ultrasound measurements and/or placenta blood-flow test results.
  • You are between 23 weeks 0 days and 31 weeks 6 days pregnant.
  • You are 18 years or older and can understand English.
  • You do not have a known major birth defect or a clear non-placental reason for the slow growth.
  • You are not taking fluvoxamine, and you are not in another study using a pill or supplement that affects oxidative stress.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05038462Recruiting
Fetal care study for babies with slow growth

This study looks at therapies meant to support brain development in babies whose growth is slower than expected before birth. It enrolls pregnancies in a specific time window and uses ultrasound/Doppler testing to make sure the baby is not likely needing delivery immediately.

Barcelona
NCT05284474Not yet recruiting
Managing early growth restriction: blood tests vs ultrasound

This study looks at two ways to manage early-onset fetal growth restriction (when a baby is smaller than expected). It compares using blood tests for angiogenic factors versus feto-placental Doppler ultrasound to guide care. The goal is to find the best way to monitor and protect your baby's health.

A Coruña
NCT04762992Enrolling by invitation· Phase 3
Heparin medicine for early slow fetal growth in one pregnancy

This study tests whether a blood-thinner medicine (LMWH) can improve outcomes for people carrying a singleton baby with early signs of slow growth. It compares LMWH against standard care to see if treatment helps the baby and pregnancy stay safer.

Lisbon
NCT07549295Enrolling by invitation· Phase 1
Melatonin to help babies grow better in the womb

This study tests whether melatonin (a natural sleep hormone) can help babies who are not growing well in the womb due to placental blood-flow problems. Researchers will measure if melatonin improves the baby's growth and health before delivery.

Shanghai, Shanghai Municipality
NCT05358834Recruiting
Melatonin study to change uterine contractions near delivery

This study tests whether taking melatonin affects uterine contractions (how strongly and how often the uterus tightens) in pregnant people close to delivery. It may help researchers understand whether melatonin can influence labor-related processes and timing.

Boston, Massachusetts
NCT07369284Not yet recruiting· Phase 2
Melatonin for blood sugar control in gestational diabetes

This trial tests whether taking melatonin (a natural sleep hormone) can help control blood sugar levels in women with gestational diabetes during pregnancy. If you have gestational diabetes, this study may offer a new way to manage your blood sugar alongside standard care.

Hear when a new Fetal Growth Retardation trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.